Caspr Biotech

About
What does Caspr Biotech do?
Caspr Biotech was a startup focused on developing portable, rapid, and affordable diagnostic kits using CRISPR technology. Their solutions aimed to detect infectious diseases and antimicrobial resistance in clinics and hospitals, providing faster and more accurate results than traditional methods. The company's technology leveraged novel Cas enzymes discovered in extreme environments.
Where is Caspr Biotech headquartered?
Caspr Biotech is headquartered in Buenos Aires, Argentina.
What industry does Caspr Biotech operate in?
Caspr Biotech operates in Biotech, MedTech, HealthTech, Drug Discovery, Diagnostics, CRISPR Technology.
What is Caspr Biotech's current status?
Caspr Biotech's current operating status is: Inactive.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.